Identification of promising small-molecule inhibitors targeting STK17B for cancer therapeutics: molecular docking and molecular dynamics investigations

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Adelusi, T. I., Abdul-Hammed, M., Idris, M. O., Oyedele, Q. K., & Adedotun, I. O. (2021). Molecular dynamics, quantum mechanics and docking studies of some Keap1 inhibitors – An insight into the atomistic mechanisms of their antioxidant potential. Heliyon, 7(6), e07317. https://doi.org/10.1016/j.heliyon.2021.e07317.
   PubMed Web of Science ®Google Scholar
• Adelusi, T. I., Oyedele, A.-Q K., Boyenle, I. D., Ogunlana, A. T., Adeyemi, R. O., Ukachi, C. D., Idris, M. O., Olaoba, O. T., Adedotun, I. O., Kolawole, O. E., Xiaoxing, Y., & Abdul-Hammed, M. (2022). Molecular modeling in drug discovery. Informatics in Medicine Unlocked, 29, 100880. 12:https://doi.org/10.1016/j.imu.2022.100880
   Google Scholar
• Boyenle, I. D., Adelusi, T. I., Ogunlana, A. T., Oluwabusola, R. A., Ibrahim, N. O., Tolulope, A., Okikiola, O. S., Adetunji, B. L., Abioye, I. O., & Oyedele, A. K. (2022a). Consensus scoring-based virtual screening and molecular dynamics simulation of some TNF-alpha inhibitors. Informatics in Medicine Unlocked, 28, 100833. https://doi.org/10.1016/j.imu.2021.100833
   Google Scholar
• Boyenle, I. D., Ogunlana, A. T., Kehinde Oyedele, A. Q., Olokodana, B. K., Owolabi, N., Salahudeen, A., Aderenle, O. T., Oloyede, T. O., & Adelusi, T. I. (2022b). Reinstating apoptosis using putative Bcl-xL natural product inhibitors: Molecular docking and ADMETox profiling investigations. Journal of Taibah University Medical Sciences, 18(3), 461–469. Nov 14 PMID: 36818176; PMCID: PMC9906007. https://doi.org/10.1016/j.jtumed.2022.10.014
   PubMed Web of Science ®Google Scholar
• Egbemhenghe, A. U., Aderemi, O. E., Omotara, B. S., Akhimien, F. I., Osabuohien, F. O., Adedapo, H. A., Temionu, O. R., Egejuru, W. A., Ajala, C. F., Ihunanya, M. F., Oluwafemi, O. O., Onu, C. F. D., Ajibare, A. C., Ddamulira, C., Abalum, J. O., & Afolayan, O. M. (2023). Computational-based drug design of novel small molecules targeting p53-MDMX interaction. Journal of Biomolecular Structure & Dynamics, Aug 14, 1–10. Epub ahead of print. PMID: 37578044. https://doi.org/10.1080/07391102.2023.2245483
   Google Scholar
• Elbadawy, M., Usui, T., Yamawaki, H., & Sasaki, K. (2018). Novel functions of death-associated protein kinases through mitogen-activated protein kinase-related signals. International Journal of Molecular Sciences, 19(10), 3031. https://doi.org/10.3390/ijms19103031
   PubMed Web of Science ®Google Scholar
• Farag, A. K., & Roh, E. J. (2019). Death-associated protein kinase (DAPK) family modulators: Current and future therapeutic outcomes. Medicinal Research Reviews, 39(1), 349–385. https://doi.org/10.1002/med.21518
   PubMed Web of Science ®Google Scholar
• Fu, L., & Liu, B. (2016). Role of autophagy in regulation survival or death of cancer cells. In Autophagy: Cancer, other pathologies, inflammation, immunity, infection, and aging (Vol. 9). Elsevier Inc. https://doi.org/10.1016/B978-0-12-802936-7.00011-8
   Google Scholar
• Fu, Y., Zhao, J., & Chen, Z. (2018). Insights into the molecular mechanisms of protein-ligand interactions by molecular docking and molecular dynamics simulation: A case of oligopeptide binding protein. Computational and Mathematical Methods in Medicine, 2018, 3502514. https://doi.org/10.1155/2018/3502514
   PubMed Web of Science ®Google Scholar
• Gimeno, A., Ojeda-Montes, M. J., Tomás-Hernández, S., Cereto-Massagué, A., Beltrán-Debón, R., Mulero, M., Pujadas, G., & Garcia-Vallvé, S. (2019). The light and dark sides of virtual screening: What is there to know? In International Journal of Molecular Sciences, 20(6), 1375. (https://doi.org/10.3390/ijms20061375
   PubMed Web of Science ®Google Scholar
• Haberkorn, U. (2007). What is cancer? Advances in Nuclear Oncology 1–16. https://doi.org/10.3109/9781420091380-2
   Google Scholar
• Hsu, K., Chen, Y., Lin, S., & Yang, J. (2011). iGEMDOCK : A graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC Bioinformatics, 12(Suppl 1), 1–11.
   Google Scholar
• Huang, J., & Mackerell, A. D. (2013). CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. Journal of Computational Chemistry, 34(25), 2135–2145. https://doi.org/10.1002/jcc.23354
   PubMed Web of Science ®Google Scholar
• Jiang, L., Zhou, J., Zhao, S., Wang, X., & Chen, Y. (2021). STK17B promotes the progression of ovarian cancer. Annals of Translational Medicine, 9(6), 475–475. https://doi.org/10.21037/atm-21-601
   PubMed Web of Science ®Google Scholar
• Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J., & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic Acids Research, 44(D1), D1202–D1213. https://doi.org/10.1093/nar/gkv951
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa–a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. Epub 2014 Jun 19. PMID: 24850022. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lan, Y., Han, J., Wang, Y., Wang, J., Yang, G., Li, K., Song, R., Zheng, T., Liang, Y., Pan, S., Liu, X., Zhu, M., Liu, Y., Meng, F., Mohsin, M., Cui, Y., Zhang, B., Subash, S., & Liu, L. (2018). STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma. Cell Death & Disease, 9(2), 236. https://doi.org/10.1038/s41419-018-0262-1
   PubMedGoogle Scholar
• Liu, C., Li, Z., Liu, Z., Yang, S., Wang, Q., & Chai, Z. (2022). Understanding the P-loop conformation in the determination of inhibitor selectivity toward the hepatocellular carcinoma-associated dark kinase STK17B. Frontiers in Molecular Biosciences, 9(May), 901603. https://doi.org/10.3389/fmolb.2022.901603
   PubMedGoogle Scholar
• Miller, B. R. 3rd, McGee, T. D. Jr., Swails, J. M., Homeyer, N., Gohlke, H., Roitberg, A. E. (2012). MMP BSA.py: An Efficient Program for End-State Free Energy Calculations. J Chem Theory Comput., 8(9), 3314–21. https://doi.org/10.1021/ct300418h.
   Google Scholar
• Mortier, J., Rakers, C., Bermudez, M., Murgueitio, M. S., Riniker, S., & Wolber, G. (2015). The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes. Drug Discovery Today, 20(6), 686–702. http://doi.org/10.1016/j.drudis.2015.01003
   PubMed Web of Science ®Google Scholar
• Naqvi, A. A., Mohammad, T., Has An, G. M., & Hasan, M. I. (2018). Advancements in docking and molecular dynamics advancement towards ligand-receptor interactions and structures-function relationships. Current Topics in Medicinal Chemistry, 18(20), 1755–1768. https://doi.org/10.2174/1568026618666181025114157
   PubMed Web of Science ®Google Scholar
• O’Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open babel. Journal of Cheminformatics, 3(33), 33. https://doi.org/10.1186/1758-2946-3-33
   PubMed Web of Science ®Google Scholar
• Ogunlana, A. T., Boyenle, I. D., Ojo, T. O., Quadri, B. O., Elegbeleye, O. E., Ogbonna, H. N., Ayoola, S. O., Badmus, I. O., Manica, A. K., Joshua, K. I., Onikute, O. W., Anamelechi, J. P., Odetunde, A., Falusi, A. G., & Oyedele, A. K. (2023). Structure-based computational design of novel covalent binders for the treatment of sickle cell disease. Journal of Molecular Graphics & Modelling, 124, 108549. Epub 2023 Jun 17. PMID: 37339569. https://doi.org/10.1016/j.jmgm.2023.108549
   PubMed Web of Science ®Google Scholar
• Oyedele, A. Q. K., Adelusi, T. I., Ogunlana, A. T., Adeyemi, R. O., Atanda, O. E., Babalola, M. O., Ashiru, M. A., Ayoola, I. J., & Boyenle, I. D. (2022). Integrated virtual screening and molecular dynamics simulation revealed promising drug candidates of p53-MDM2 interaction. Journal of Molecular Modeling, 28(6), 142. https://doi.org/10.1007/s00894-022-05131-w
   PubMed Web of Science ®Google Scholar
• Oyedele, A. Q. K., Ogunlana, A. T., Boyenle, I. D., Ibrahim, N. O., Gbadebo, I. O., Owolabi, N. A., Ayoola, A. M., Francis, A. C., Eyinade, O. H., & Adelusi, T. I. (2022). Pharmacophoric analogs of sotorasib-entrapped KRAS G12C in its inactive GDP-bound conformation: Covalent docking and molecular dynamics investigations. Molecular Diversity, 27(4), 1795–1807. https://doi.org/10.1007/s11030-022-10534-1
   PubMed Web of Science ®Google Scholar
• Picado, A., Chaikuad, A., Wells, C. I., Shrestha, S., Zuercher, W. J., Pickett, J. E., Kwarcinski, F. E., Sinha, P., De Silva, C. S., Zutshi, R., Liu, S., Kannan, N., Knapp, S., Drewry, D. H., & Willson, T. M. (2020). A chemical probe for dark kinase STK17B derives its potency and high selectivity through a unique p-loop conformation. Journal of Medicinal Chemistry, 63(23), 14626–14646. https://doi.org/10.1021/acs.jmedchem.0c01174
   PubMed Web of Science ®Google Scholar
• Shi, X., Zhou, Q., Huang, B., Xia, S., Jiang, Y., Fang, S., & Lin, J. (2022). Prognostic and immune-related value of STK17B in skin cutaneous melanoma. PloS One, 17(2), e0263311. https://doi.org/10.1371/journal.pone.0263311
   PubMed Web of Science ®Google Scholar
• Szoltysek, K., Ciardullo, C., Zhou, P., Walaszczyk, A., Willmore, E., Rand, V., Marshall, S., Hall, A., Harrison, C. J., Eswaran, J., & Soundararajan, M. (2020). Dap kinase-related apoptosis-inducing protein kinase 2 (Drak2) is a key regulator and molecular marker in chronic lymphocytic leukemia. International Journal of Molecular Sciences, 21(20), 7663. https://doi.org/10.3390/ijms21207663
   PubMed Web of Science ®Google Scholar
• Valdés-Tresanco, M. S., Valdés-Tresanco, M. E., Valiente, P. A., & Moreno, E. (2021). gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS. Journal of Chemical Theory and Computation, 17(10), 6281–6291. Epub 2021 Sep 29. PMID: 34586825. https://doi.org/10.1021/acs.jctc.1c00645
   PubMed Web of Science ®Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005). GROMACS: Fast, flexible, and free. In Journal of Computational Chemistry, 26Issue (16), 1701–1718. (https://doi.org/10.1002/jcc.2029
   PubMed Web of Science ®Google Scholar
• Wang, C., Greene, D., Xiao, L., Qi, R., & Luo, R. (2017). Jan 10 Recent Developments and Applications of the MMPBSA Method. Frontiers in Molecular Biosciences, 4, 87. PMID: 29367919; PMCID: PMC5768160. https://doi.org/10.3389/fmolb.2017.00087
   PubMed Web of Science ®Google Scholar
• Wang, C., Nguyen, P. H., Pham, K., Huynh, D., Le, T. B., Wang, H., Ren, P., & Luo, R. (2016). Calculating protein-ligand binding affinities with MMPBSA: Method and error analysis. Journal of Computational Chemistry, 37(27), 2436–2446. Epub 2016 Aug 11. PMID: 27510546; PMCID: PMC5018451 https://doi.org/10.1002/jcc.24467
   PubMed Web of Science ®Google Scholar
• World Health Organisation (WHO). (2022). Cancer. Retrieved from https://www.who.int/news-room/fact-sheets/detail/cancer.
   Google Scholar